Douglas Barry - 03 Feb 2025 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Reporting relationship: General Counsel
Issuer ticker: TNGX
Reported as of: 03 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Feb 2025, 19:30:12 UTC
Prior SEC filing: 08 Feb 2024
Next SEC filing: 06 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Douglas Barry

Key filing fact

Douglas Barry filed Form 4 for Tango Therapeutics, Inc. (TNGX) on 05 Feb 2025.

Key facts

This page summarizes Douglas Barry's Form 4 filing for Tango Therapeutics, Inc. (TNGX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Feb 2025, 19:30.

Change

Previous filing in this sequence was filed on 08 Feb 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNGX transaction

Common Stock

Award

Transaction value: $0
Shares: +27,363
Change %: +62%
Price: $0.000000
Shares after: 71,344
Date: 03 Feb 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNGX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +164,175
Change %
Price: $0.000000
Shares after: 164,175
Date: 03 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 164,175
Exercise price: $2.91
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 2, 2026, 33% on February 1, 2027 and 34% on February 14, 2028, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Footnote F2

This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.